Simvastatin induced ferroptosis for triple-negative breast cancer therapy

Triple-negative breast cancer (TNBC), a management of aggressive breast cancer, remains an unmet medical challenge. Although a wave of efforts had spurred to design novel therapeutic method of TNBC, unpredictable prognosis with lacking effective therapeutic targets along with the resistance to apopt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xianxian, Xie, Ruihong, Cao, Yongbin, Tang, Jing, Men, Yongzhi, Peng, Haibao, Yang, Wuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502296/
https://www.ncbi.nlm.nih.gov/pubmed/34627266
http://dx.doi.org/10.1186/s12951-021-01058-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502296/
https://www.ncbi.nlm.nih.gov/pubmed/34627266
http://dx.doi.org/10.1186/s12951-021-01058-1

Ejemplares similares